Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from October 18, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 16, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$34.29 Published $38.05 Target $37.76 Window close $38.23 Peak
$33.39 – $34.37Entry zone — fair-value band
$34.29Published — price the day we called it
$38.05Target — the price the thesis aimed for
$38.23Peak — highest point inside the window, not a realized return
$37.76Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price
$38.23
peak on January 9, 2026 — not a realized return
Peak gain
+11.5%
peak, from the publication price
Window close
$37.76
end-of-window price, context only
Days to target
Window
October 18, 2025 – January 16, 2026

The thesis — published October 18, 2025

Predicted growth
+12%
over the measurement window
Target price
$38.05
the price the thesis aimed for
Entry zone
$33.39 – $34.37
the fair-value band we waited for
Price at publication
$34.29
published October 18, 2025
Confidence
84%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CareTrust REIT looks set for a steady climb. The company keeps adding care homes, including a recent $27M purchase in the UK, which boosts rent income and spreads risk. Many see fair value near $36.89, so today's price still leaves upside. With investors favoring dependable dividends and rate swings calming down, healthcare landlords like CareTrust can attract more income-focused money over the next few months.

Primary drivers

  • Recent price momentum and upbeat mood suggest buyers are in control
  • New UK properties add more rent checks and spread risk across markets
  • Shares trade below many fair-value estimates, leaving room for upside
  • Calmer interest rates make income-focused real estate more attractive

How it played out

CTRE: peak topped the target late in the window

Lyra published CTRE at 34.29 on 2025-10-18 with 12% expected growth. The thesis pointed to recent price momentum, new UK properties, shares below many fair-value estimates, and calmer interest rates that could help income-focused real estate.

Inside the window, CTRE peaked at 38.23 on 2026-01-09 versus the 38.05 target. The peak gain was 11.5%. No target day was recorded in the data. The stock ended the window at 37.76 on 2026-01-16. The thesis mostly played out, but it did not cleanly match the expected 12%.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.